Top Story

Self-reported exercise assessments offer clue to cardiometabolic risks

December 22, 2014

Read the Perspective from Sheri R. Colberg, PhD, FACSM

Clinicians could glean additional information about patients’ cardiometabolic risk factors through routine clinical physical activity assessments, according to research published in Preventing Chronic Disease.

“A simple, two-question physical activity assessment performed in the clinic may give health providers additional information about their patients’ cardiometabolic risk,” Deborah Rohm Young, PhD, of the Kaiser Permanente Department of Research and Evaluation in Pasadena, California, told Endocrine Today. “If a person is consistently inactive, they are likely to have increased cardiometabolic risk, and the consistently active are likely to have the lowest risk.”

Hans-Christoph Diener, MD, PhD

New trial will assess dabigatran for prevention of recurrent stroke

December 21, 2014
The first patient has been enrolled in the RE-SPECT ESUS study, which will investigate the safety of dabigatran etexilate for the prevention of recurrent embolic stroke…

CVD care improved across US hospitals from 2009 to 2013

December 20, 2014
The quality of care for patients with MI, HF, stroke and venous thromboembolism has improved across hospitals in the United States in recent years, according to an…
In the Journals

Stressful duties increased sudden cardiac death risk for police officers

December 19, 2014
Police officers engaged in stressful law enforcement duties such as suspect pursuits or rescue operations had a greater risk for sudden cardiac death compared with…
In the Journals

PCI process measures may not correlate with 30-day mortality

December 19, 2014
CHICAGO — Hospital performance measures for PCI processes failed to demonstrate an association with 30-day risk-standardized mortality rates, according to report…
More News Headlines »
CME
Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

This activity is supported by educational grants from Lilly USA, LLC and Novo Nordisk.

The prevalence of type 2 diabetes mellitus has escalated in recent years and targeting treatmentcontinues to be a…
More »
Meeting News Coverage Video
Healio AHA2014 Bhatt1 th

VIDEO: Deepak L. Bhatt, MD, MPH, discusses 'practice-changing' IMPROVE-IT results

December 14, 2014
CHICAGO — The "practice-changing" results from the IMPROVE-IT trial presented at the American Heart Association…
More »
CME
Lipid Forum II Highlights

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »
morganatic-roan